| 益生菌缓解或治疗炎症性肠病的作用及机制研究进展 |
| |
| 引用本文： | 徐康,王哲,薛志朋,王家朋,徐振上,王婷. 益生菌缓解或治疗炎症性肠病的作用及机制研究进展[J]. 食品工业科技, 2022, 43(20): 414-420. DOI: 10.13386/j.issn1002-0306.2021090166 |
| |
| 作者姓名： | 徐康 王哲 薛志朋 王家朋 徐振上 王婷 |
| |
| 作者单位： | 齐鲁工业大学（山东省科学院）生物工程学院，山东济南 250353 |
| |
| 基金项目： | 山东省重大科技创新工程（2020CXGC010602）；国家自然科学基金青年基金（31901665）；山东省高等学校青创计划（2020KJE005）。 |
| |
| 摘 要： | 炎症性肠病（inflammatory bowel disease，IBD）是一种慢性且反复发作的肠道炎症性疾病，并且在中国的发病率逐渐升高。近年来，随着对IBD的深入研究，益生菌成为IBD治疗的新兴药物，并且某些益生菌能够通过参与肠道屏障的保护，调节免疫和炎性因子的表达来缓解或治疗IBD。同时，因益生菌具有抗炎、良好的耐受性和极少的不良反应等特性，也使其在IBD治疗的临床应用中越来越常见。本文主要从缓解或治疗IBD的益生菌分类、作用机制及临床研究等方面介绍了益生菌在IBD治疗中的研究进展。
|
| 关 键 词： | 益生菌 炎症性肠病（IBD） 作用机制 临床研究 |
| 收稿时间： | 2021-09-14 |
Effect and Mechanism of Probiotics in Alleviating or Treating Inflammatory Bowel Disease |
| |
| XU Kang,WANG Zhe,XUE Zhipeng,WANG Jiapeng,XU Zhenshang,WANG Ting. Effect and Mechanism of Probiotics in Alleviating or Treating Inflammatory Bowel Disease[J]. Science and Technology of Food Industry, 2022, 43(20): 414-420. DOI: 10.13386/j.issn1002-0306.2021090166 |
| |
| Authors: | XU Kang WANG Zhe XUE Zhipeng WANG Jiapeng XU Zhenshang WANG Ting |
| |
| Affiliation: | School of Biological Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China |
| |
| Abstract: | Inflammatory bowel disease (IBD), gradually increasing in China, is a chronic and recurrent intestinal inflammatory disease. Recently, probiotics have been applied for the treatment of IBD, and some probiotic strains can alleviate or treat IBD by protection of the intestinal barrier and regulating expression of immune and inflammatory factors. Meanwhile, probiotics have the characteristics of good tolerability and few adverse reactions, resulting in their commonness in the clinical application of IBD treatment. This article mainly introduces the research progress of probiotics in the treatment of IBD, including the classification, mechanism of action and clinical research. |
| |
| Keywords: | |
|
| 点击此处可从《食品工业科技》浏览原始摘要信息 |
|
点击此处可从《食品工业科技》下载全文 |
|
